tiprankstipranks
Perspective Therapeutics (CATX)
:CATX
US Market
CATX
Perspective Therapeutics
RESEARCH TOOLSreports
Want to see CATX full AI Analyst Report?

Perspective Therapeutics (CATX) Financial Statements

1,655 Followers

Perspective Therapeutics Financial Overview

Perspective Therapeutics's market cap is currently $375.56M. The company's EPS TTM is $-1.56; its P/E ratio is -2.03; Perspective Therapeutics is scheduled to report earnings on August 10, 2026, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 1.45M$ 1.43M$ 7.10M$ 10.79M
Gross Profit$ 0.00$ -852.00K$ 1.43M$ 1.63M$ 4.62M
Operating Income$ -113.56M$ -66.80M$ -40.94M$ -15.18M$ -7.39M
EBITDA$ -100.80M$ -64.49M$ -39.96M$ -14.84M$ -7.14M
Net Income$ -103.12M$ -79.28M$ -46.51M$ -14.67M$ -7.27M
Balance Sheet
Cash & Short-Term Investments$ 144.74M$ 226.92M$ 9.24M$ 43.76M$ 55.89M
Total Assets$ 266.97M$ 341.10M$ 97.89M$ 58.09M$ 64.44M
Total Debt$ 3.25M$ 4.06M$ 2.55M$ 524.00K$ 524.00K
Net Debt$ -27.38M$ -57.52M$ -6.69M$ -20.47M$ -55.37M
Total Liabilities$ 59.94M$ 50.43M$ 22.71M$ 3.45M$ 3.16M
Stockholders' Equity$ 207.03M$ 290.67M$ 75.18M$ 54.64M$ 61.28M
Cash Flow
Free Cash Flow$ -95.23M$ -72.71M$ -37.98M$ -10.68M$ -7.98M
Operating Cash Flow$ -82.48M$ -18.29M$ -36.91M$ -10.40M$ -7.71M
Investing Cash Flow$ 41.23M$ -218.93M$ 24.37M$ -28.99M$ -284.00K
Financing Cash Flow$ 10.30M$ 289.38M$ 785.00K$ 28.00K$ 56.00K
Currency in USD

Perspective Therapeutics Earnings and Revenue History

Income Statement >

Perspective Therapeutics Debt to Assets

Balance Sheet >

Perspective Therapeutics Cash Flow

Cash Flow >

Perspective Therapeutics Forecast EPS vs Actual EPS

Earnings >